Simon Panzer

Versbacher Str. 3
Wuerzburg, BY 97078, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 127 publications

GDF-15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical Outcomes.

GDF-15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical Outcomes.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: November 22, 2025

Sex-Related Differences in On-Treatment Platelet Reactivity in Patients with Acute Coronary Syndrome.

Sex-Related Differences in On-Treatment Platelet Reactivity in Patients with Acute Coronary Syndrome.

Journal: Biomedicines

Published: August 04, 2025

Elderly patients are hyperresponsive to potent P2Y12 inhibitors.

Elderly patients are hyperresponsive to potent P2Y12 inhibitors.

Journal: Research and practice in thrombosis and haemostasis

Published: October 06, 2024

Platelet reactivity is associated with pump thrombosis in patients with left ventricular assist devices.

Platelet reactivity is associated with pump thrombosis in patients with left ventricular assist devices.

Journal: Research and practice in thrombosis and haemostasis

Published: March 19, 2024

Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis.

Decreased platelet activation predicts hepatic decompensation and mortality in patients with cirrhosis.

Journal: Hepatology (Baltimore, Md.)

Published: August 13, 2023

Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension-A Prospective Study.

Platelet Function Decreases with Increasing Severity of Liver Cirrhosis and Portal Hypertension-A Prospective Study.

Journal: Thrombosis and haemostasis

Published: July 30, 2023

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome.

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome.

Journal: Journal of clinical medicine

Published: December 30, 2022

Microvascular Thrombosis as a Critical Factor in Severe COVID-19.

Microvascular Thrombosis as a Critical Factor in Severe COVID-19.

Journal: International journal of molecular sciences

Published: December 17, 2022

Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices.

Impact of ABO Blood Group on Thromboembolic and Bleeding Complications in Patients with Left Ventricular Assist Devices.

Journal: Thrombosis and haemostasis

Published: November 19, 2022

Impact of body size on platelet function in patients with acute coronary syndrome on dual antiplatelet therapy.

Impact of body size on platelet function in patients with acute coronary syndrome on dual antiplatelet therapy.

Journal: Vascular pharmacology

Published: May 17, 2022

Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y12 Inhibitors.

Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y12 Inhibitors.

Journal: Journal of cardiovascular pharmacology and therapeutics

Published: April 28, 2022

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices.

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: March 18, 2022

Showing 1-12 of 127

Last Updated: 09/26/2026